{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:07Z","timestamp":1786993987969,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21DE032584-01"],"award-info":[{"award-number":["1R21DE032584-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.mayocpiqo.2025.100597","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:44:39Z","timestamp":1739976279000},"page":"100597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Medication and Therapy Profiles for Pain and Symptom Management Among Adults With Cerebral Palsy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9861-4275","authenticated-orcid":false,"given":"Mark D.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ashbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Haapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Hurvitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.mayocpiqo.2025.100597_bib1","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJMp2403366","article-title":"Reframing cerebral palsy as a lifelong physical disability","volume":"391","author":"Peterson","year":"2024","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100597_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/dmcn.12268","article-title":"Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning \u2013 autism and developmental disabilities monitoring network, USA, 2008","volume":"56","author":"Christensen","year":"2014","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2025.100597_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.annepidem.2016.01.001","article-title":"Prevalence of cerebral palsy and intellectual disability among children identified in two U.S. national Surveys, 2011-2013","volume":"26","author":"Maenner","year":"2016","journal-title":"Ann Epidemiol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2025.100597_bib4","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/jamaneurol.2024.2443","article-title":"Pain phenotypes and pain multimorbidity among medicare beneficiaries with cerebral palsy","volume":"81","author":"Peterson","year":"2024","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2025.100597_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/dmcn.13930","article-title":"Pathophysiology of chronic pain in cerebral palsy: implications for pharmacological treatment and research","volume":"60","author":"Blackman","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.mayocpiqo.2025.100597_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/dmcn.13477","article-title":"Pain in cerebral palsy: a neglected comorbidity","volume":"59","author":"Fehlings","year":"2017","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100597_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.14678","article-title":"Prevalence of pain and interference with daily activities and sleep in adults with cerebral palsy","volume":"63","author":"Rodby-Bousquet","year":"2021","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2025.100597_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01376517-200410000-00004","article-title":"Pain in children with cerebral palsy: a review","volume":"36","author":"McKearnan","year":"2004","journal-title":"J\u00a0Neurosci Nurs"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2025.100597_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-0404.2005.00468.x","article-title":"Entrapment neuropathy in patients with spastic cerebral palsy","volume":"112","author":"Frascarelli","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2025.100597_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ana.26040","article-title":"Adults with cerebral palsy require ongoing neurologic care: A systematic review","volume":"89","author":"Smith","year":"2021","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2025.100597_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/dmcn.15102","article-title":"Classification of pain in children with cerebral palsy","volume":"64","author":"Vinkel","year":"2022","journal-title":"Dev Med Child Neurol"},{"issue":"15","key":"10.1016\/j.mayocpiqo.2025.100597_bib12","first-page":"3203","article-title":"Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future","volume":"10","author":"Nijs","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.mayocpiqo.2025.100597_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.734139","article-title":"Navigating the pathway to care in adults with cerebral palsy","volume":"12","author":"Hurvitz","year":"2021","journal-title":"Front Neurol"},{"issue":"1-2","key":"10.1016\/j.mayocpiqo.2025.100597_bib15","first-page":"59","article-title":"ICD-10 codes for the study of chronic overlapping pain conditions in administrative databases","volume":"21","author":"Schrepf","year":"2020","journal-title":"J\u00a0Pain"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2025.100597_bib16","doi-asserted-by":"crossref","first-page":"486.e1","DOI":"10.1016\/j.ajog.2018.06.010","article-title":"Definition development and prevalence of new persistent opioid use following hysterectomy","volume":"219","author":"Swenson","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2025.100597_bib17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/ALN.0000000000003164","article-title":"Opioid fills for lumbar facet radiofrequency ablation associated with new persistent opioid use","volume":"132","author":"Southren","year":"2020","journal-title":"Anesthesiol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2025.100597_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2025.100597_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.dhjo.2022.101279","article-title":"Physical and occupational therapy utilization and associated factors among adults with cerebral palsy: longitudinal modelling to capture distinct utilization groups","volume":"15","author":"Conner","year":"2022","journal-title":"Disabil Health J"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2025.100597_bib20","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/CPJ.0000000000001113","article-title":"Pain phenotypes in adults living with cerebral palsy","volume":"11","author":"Peterson","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2025.100597_bib21","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1097\/j.pain.0000000000002240","article-title":"Pain phenotypes among adults living with cerebral palsy and spina bifida","volume":"162","author":"Peterson","year":"2021","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2025.100597_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11096-023-01553-5","article-title":"Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study","volume":"45","author":"Whitney","year":"2023","journal-title":"Int J Clin Pharm"},{"issue":"10289","key":"10.1016\/j.mayocpiqo.2025.100597_bib25","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2025.100597_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41582-024-00966-8","article-title":"Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms","volume":"20","author":"Kaplan","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.mayocpiqo.2025.100597_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09918","article-title":"Opioid prescription patterns among adults with cerebral palsy and spina bifida","volume":"8","author":"Peterson","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.mayocpiqo.2025.100597_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.722971","article-title":"Evaluation of pain in adults with childhood-onset disabilities and communication difficulties","volume":"12","author":"Jersak","year":"2021","journal-title":"Front Neurol"},{"issue":"24","key":"10.1016\/j.mayocpiqo.2025.100597_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192417095","article-title":"Withdrawing antipsychotics for challenging behaviours in adults with intellectual disabilities: experiences and views of prescribers","volume":"19","author":"de Kuijper","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100597_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.2007.02961.x","article-title":"OLDY (OLd people Drugs & dYsregulations) Study Group. Relationship between polypharmacy and underprescribing","volume":"65","author":"Kuijpers","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2025.100597_bib29","first-page":"51","article-title":"Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy","volume":"27","author":"Whitney","year":"2021","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2025.100597_bib30","first-page":"1153","article-title":"Polypharmacy among privately insured adults with cerebral palsy: A retrospective cohort study","volume":"26","author":"Whitney","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454825000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454825000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:38:36Z","timestamp":1744868316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454825000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2542454825000086"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2025.100597","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication and Therapy Profiles for Pain and Symptom Management Among Adults With Cerebral Palsy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2025.100597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}],"article-number":"100597"}}